Just reviewed the secondary CV outcomes of this prim prev data set with residents in our EBM course @NorthwellDGIM - same - no ⬇️CVA/MI/CV m/m w st signif hemorrhage (100mg asa, Australian/US, 5-7%minority). Much needed negative study. First no harm. h
RT @geri_doc: Low dose aspirin in those over age 65 without heart disease did not reduce disability but did increase bleeding and all cause…
RT @geri_doc: Low dose aspirin in those over age 65 without heart disease did not reduce disability but did increase bleeding and all cause…
RT @geri_doc: Low dose aspirin in those over age 65 without heart disease did not reduce disability but did increase bleeding and all cause…
RT @geri_doc: Low dose aspirin in those over age 65 without heart disease did not reduce disability but did increase bleeding and all cause…
RT @geri_doc: Low dose aspirin in those over age 65 without heart disease did not reduce disability but did increase bleeding and all cause…
Low dose aspirin in those over age 65 without heart disease did not reduce disability but did increase bleeding and all cause mortality. Aspirin should not be used for primary prevention in older persons #geriatrics https://t.co/YimtxU4zzY
Does aspirin use prolong disability-free survival? Read more in the New England Journal of Medicine: https://t.co/j6xrRsROkG
Excellent journal club today by Dr. Gina Kim! What's your take on these varied composite outcomes? Effect of Aspirin on Disability-free Survival in the Healthy Elderly | NEJM https://t.co/fSSCV4pyIH @NEJM @RachelStarkMD @RebeccaRogersMD https://t.co/Uwe5
Aspirin daily in healthy individuals (>70 yrs) no more effective than placebo at preventing death, dementia or physical disability. It did increase the risk of bleeding. Take home messages: stay slim; take exercise; don't smoke & avoid aspirin @NEJM
RT @gustavobonzon: El Estudio ASPREE confirma que, en adultos mayores sanos, la Aspirina a dosis bajas no mejora la discapacidad y mortalid…
#Aspirin for primary prevention now proven bad idea. https://t.co/uE8mufXJ49 Four different articles in #NEJM this week that ALL disprove value for people without a history of heart attack or stroke. https://t.co/uE8mufXJ49
RT @gustavobonzon: El Estudio ASPREE confirma que, en adultos mayores sanos, la Aspirina a dosis bajas no mejora la discapacidad y mortalid…
RT @gustavobonzon: El Estudio ASPREE confirma que, en adultos mayores sanos, la Aspirina a dosis bajas no mejora la discapacidad y mortalid…
RT @gustavobonzon: El Estudio ASPREE confirma que, en adultos mayores sanos, la Aspirina a dosis bajas no mejora la discapacidad y mortalid…
RT @gustavobonzon: El Estudio ASPREE confirma que, en adultos mayores sanos, la Aspirina a dosis bajas no mejora la discapacidad y mortalid…
RT @gustavobonzon: El Estudio ASPREE confirma que, en adultos mayores sanos, la Aspirina a dosis bajas no mejora la discapacidad y mortalid…
RT @gustavobonzon: El Estudio ASPREE confirma que, en adultos mayores sanos, la Aspirina a dosis bajas no mejora la discapacidad y mortalid…
RT @gustavobonzon: El Estudio ASPREE confirma que, en adultos mayores sanos, la Aspirina a dosis bajas no mejora la discapacidad y mortalid…
RT @gustavobonzon: El Estudio ASPREE confirma que, en adultos mayores sanos, la Aspirina a dosis bajas no mejora la discapacidad y mortalid…
@Univalle_FSalud @cmimbanaco @FSFB_Salud
RT @gustavobonzon: El Estudio ASPREE confirma que, en adultos mayores sanos, la Aspirina a dosis bajas no mejora la discapacidad y mortalid…
RT @gustavobonzon: El Estudio ASPREE confirma que, en adultos mayores sanos, la Aspirina a dosis bajas no mejora la discapacidad y mortalid…
El Estudio ASPREE confirma que, en adultos mayores sanos, la Aspirina a dosis bajas no mejora la discapacidad y mortalidad. Por el contrario, aumenta la probabilidad de hemorragias, algunas de ellas peligrosas para la vida. https://t.co/8bpKB49NeG
RT @NEJM: ASPREE trial: Effect of Aspirin on Disability-free Survival in the Healthy Elderly https://t.co/QUFKIcTuPI Editorial: Should Asp…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @ryoma_tanaka: アスピリンについてのスタディーが3つNEJMに発表されましたね。 出血が増えて悪性疾患が増えて心血管疾患は減らなくて、死亡リスクは増えるという何だか大変な結果になっています。 https://t.co/tdsfmj8miC https://t…
RT @NEJM: ASPREE trial: Effect of Aspirin on Disability-free Survival in the Healthy Elderly https://t.co/QUFKIcTuPI Editorial: Should Asp…
RT @emas_online: Effect of Aspirin on Disability-free Survival in the Healthy Elderly | NEJM https://t.co/AAFAQ1bclP
RT @NEJM: Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate…
RT @NEJM: ASPREE trial: Effect of Aspirin on Disability-free Survival in the Healthy Elderly https://t.co/QUFKIcTuPI Editorial: Should Asp…
RT @prof_cameron: Aspirin not so harmless after all - in Emergency medicine we are seeing more complications from falls and minor injuries…
Effect of Aspirin on Disability-free Survival in the Healthy Elderly | NEJM https://t.co/AAFAQ1bclP
RT @NEJM: ASPREE trial: Effect of Aspirin on Disability-free Survival in the Healthy Elderly https://t.co/QUFKIcTuPI Editorial: Should Asp…
RT @VivekSubbiah: Glad we did not add aspirin to the city water supply based on previous studies 👉 Sunday 🤔 what do you say @Aiims1742 @nee…
RT @NEJM: ASPREE trial: Effect of Aspirin on Disability-free Survival in the Healthy Elderly https://t.co/QUFKIcTuPI Editorial: Should Asp…
RT @NEJM: ASPREE trial: Effect of Aspirin on Disability-free Survival in the Healthy Elderly https://t.co/QUFKIcTuPI Editorial: Should Asp…
RT @NEJM: ASPREE trial: Effect of Aspirin on Disability-free Survival in the Healthy Elderly https://t.co/QUFKIcTuPI Editorial: Should Asp…
RT @NEJM: ASPREE trial: Effect of Aspirin on Disability-free Survival in the Healthy Elderly https://t.co/QUFKIcTuPI Editorial: Should Asp…
RT @NEJM: ASPREE trial: Effect of Aspirin on Disability-free Survival in the Healthy Elderly https://t.co/QUFKIcTuPI Editorial: Should Asp…
Should Aspirin Be Used for Primary Prevention in the Post-Statin Era? The answers seems to be a definite "No"
RT @NEJM: ASPREE trial: Effect of Aspirin on Disability-free Survival in the Healthy Elderly https://t.co/QUFKIcTuPI Editorial: Should Asp…
RT @NEJM: ASPREE trial: Effect of Aspirin on Disability-free Survival in the Healthy Elderly https://t.co/QUFKIcTuPI Editorial: Should Asp…
RT @NEJM: ASPREE trial: Effect of Aspirin on Disability-free Survival in the Healthy Elderly https://t.co/QUFKIcTuPI Editorial: Should Asp…
RT @NEJM: ASPREE trial: Effect of Aspirin on Disability-free Survival in the Healthy Elderly https://t.co/QUFKIcTuPI Editorial: Should Asp…
RT @NEJM: ASPREE trial: Effect of Aspirin on Disability-free Survival in the Healthy Elderly https://t.co/QUFKIcTuPI Editorial: Should Asp…
ASPREE trial: Effect of Aspirin on Disability-free Survival in the Healthy Elderly https://t.co/QUFKIcTuPI Editorial: Should Aspirin Be Used for Primary Prevention in the Post-Statin Era? https://t.co/NzO4IcMndP https://t.co/XJ4YhZMtgp
RT @NEJM: Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate…
RT @drjohnmorley: Effect of Aspirin on Disability-free Survival in the Healthy Elderly | NEJM https://t.co/9fqrcdzbKy
La aspirina no debería indicarse como prevención primaria a todos los pacientes. El riesgo de sangrado supera los beneficios. Aquí los datos ⬇️
La aspirina no previene de la #discapacidad @NEJM https://t.co/48opSHqRrH
RT @prof_cameron: Aspirin not so harmless after all - in Emergency medicine we are seeing more complications from falls and minor injuries…
RT @NEJM: Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate…
RT @NEJM: Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate…
RT @NEJM: Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate…
RT @NEJM: Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate…
en mayores sanos, no administrar AAS, riesgo de sangrado sin beneficio.
No hay beneficio significativo en pacientes mayores al tomar aspirina como prevención primaria. https://t.co/I2c10mKa4P
RT @NEJM: Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate…
RT @jvillacastin: Effect of Aspirin on Disability-free Survival in the Healthy Elderly | NEJM https://t.co/mYN50mXBz5
Aspirin use in healthy elderly persons did not prolong disability-free survival but leads to high bleeding rate. Less is better! Effect of Aspirin on Disability-free Survival in the Healthy Elderly | NEJM https://t.co/CZAT1hVGSK
Effect of Aspirin on Disability-free Survival in the Healthy Elderly | NEJM https://t.co/9fqrcdzbKy
RT @NEJM: Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate…
RT @NEJM: Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate…
RT @harroford: Añadir aspirina en ancianos sanos no redundó en ningún beneficio y además incrementó el riesgo de eventos hemorrágicos. Effe…
RT @NEJM: Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate…
Añadir aspirina en ancianos sanos no redundó en ningún beneficio y además incrementó el riesgo de eventos hemorrágicos. Effect of Aspirin on Disability-free Survival in the Healthy Elderly | NEJM https://t.co/AJwpdrOHeF
RT @Drlipid: Aspirin use in HEALTHY elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher r…
RT @NEJM: Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate…
🆕 📢 Effect of Aspirin on Disability-free Survival in the Healthy Elderly https://t.co/tDPV4Wmbt5
Stort sett dræpen for Aspirin i flere artikler i siste NEJM https://t.co/mk8q6cGpsI
RT @NEJM: Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate…
Effect of Aspirin on Disability-free Survival in the Healthy Elderly | NEJM https://t.co/ChFxQItks1. NO es útil
RT @NEJM: Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate…
RT @NEJM: Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate…
Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate of major hemorrhage than placebo https://t.co/PFKes7dYtG
Effect of Aspirin on Disability-free Survival in the Healthy Elderly | NEJM https://t.co/mYN50mXBz5
RT @Benettivan: Aspirin in healthy elderly persons didn't prolong disability-free survival over 5 years but led to higher rate of major hem…
Aspirin in healthy elderly persons didn't prolong disability-free survival over 5 years but led to higher rate of major hemorrhage than placebo. of Aspirin on Disability-free Survival in the Healthy Elderly | NEJM https://t.co/tKGNdFUqzx
RT @NEJM: Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate…
RT @NEJM: Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate…
RT @NEJM: Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate…
RT @NEJM: Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate…
https://t.co/dssiBS7qGO 心血管系イベントや痴呆などをもたない70歳以上の高齢者に、継続的なアスピリン投与(100mg/day)が死亡、痴呆、身体障害を防ぐかどうかを調べた大規模RCT #当麻_凝固
Effect of Aspirin on Disability-free Survival in the Healthy Elderly | NEJM https://t.co/JlMt2Lr9iQ
RT @NEJM: Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate…
RT @NEJM: Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate…
Effect of Aspirin on Disability-free Survival in the Healthy Elderly | NEJM https://t.co/QvZX8hoQpX
RT @NEJM: Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate…
RT @NEJM: Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate…
Big longitudinal studies find no benefit in elderly of daily aspirin on disability free survival https://t.co/QQbcXnPD9e; all-cause mortality https://t.co/qorqPncf0z ; prevented major CV events in diabetics but caused major bleeds https://t.co/qorqPncf0z
RT @NEJM: Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate…
RT @Drlipid: Aspirin use in HEALTHY elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher r…
RT @DanielJDrucker: The bruises aren't worth it Multiple new studies on lack of primary prevention benefit for ASA | @NEJM https://t.co/Y7…
RT @Drlipid: Aspirin use in HEALTHY elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher r…
Aspirin use in HEALTHY elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate of major hemorrhage than placebo. Key word is HEALTHY - As with all Rx, therapeutic advice requires individualization https
RT @NEJM: Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate…
RT @DanielJDrucker: The bruises aren't worth it Multiple new studies on lack of primary prevention benefit for ASA | @NEJM https://t.co/Y7…